by CN Bio. | Jun 24, 2021 | Business
Today we signed a supply agreement with Dutch Company Cell4Pharma to access their industry-validated conditionally immortalised Renal Proximal Tubule Epithelial Cell (ciPTEC) lines for use with our PhysioMimix OOC Systems. Our PhysioMimix OOC systems, which are...
by CN Bio | Jun 19, 2018 | Business
View this webinar by industry specialists Xtalks to discover how to run Organ-on-a-Chip studies in your own lab to enhance research. The webinar covers: Walkthrough of an Organ-on-Chip workflow: lab set-up, seeding and culturing cells, dosing, sampling and analysis...
by CN Bio | Mar 2, 2018 | Business
Dr David Hughes, Chief Technical Officer at Organ-on-Chip specialist CN Bio Innovations will be presenting a poster at the American Association for Cancer Research Annual Meeting 2018. The poster will cover the company’s MicroMix technology. MicroMix uses pumps and...
by CN Bio | Feb 22, 2018 | Business
As new drug treatments are developed, quicker and much more precise technology which predicts the effect these chemical and biological substances have on human organs are also becoming available. These technologies will be important particularly for pharmaceutical and...
by CN Bio | Dec 15, 2017 | Business
A cell-culture technology now being developed by London biotech CN Bio Innovations and its global pharmaceutical company partner, has won one of the scientific world’s premier awards – known as the “Oscars of Innovation”. A team of Vanderbilt...
by CN Bio | Jun 13, 2016 | Business
MIT and CN Bio Innovations today announced that the world’s first 7-organ “Human-on-a-Chip” platform will be showcased at the Organ-on-Chip congress in Boston on the 7th and 8th of July 2016. Under a $26M Defense Advanced Research Projects Agency (DARPA) contract...
